LEADER 02068nam  2200637Ia 450 
001 9910456012803321
005 20200520144314.0
010   $a1-280-18355-1
010   $a9786610183555
010   $a0-309-56610-X
035   $a(CKB)111069351128584
035   $a(SSID)ssj0000176890
035   $a(PQKBManifestationID)11165321
035   $a(PQKBTitleCode)TC0000176890
035   $a(PQKBWorkID)10209408
035   $a(PQKB)10674403
035   $a(MiAaPQ)EBC3377265
035   $a(Au-PeEL)EBL3377265
035   $a(CaPaEBR)ebr10068512
035   $a(CaONFJC)MIL18355
035   $a(OCoLC)923269360
035   $a(EXLCZ)99111069351128584
100   $a20040120d2002      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aImmunization safety review$b[electronic resource] $ehepatitis B vaccine and demyelinating neurological disorders /$fKathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors
210   $aWashington, D.C. ;$a[Great Britain] $cNational Academies Press$dc2002
215   $axiv, 106 p. $cill
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-08469-5 
320   $aIncludes bibliographical references (p. 85-90).
606   $aHepatitis B$xVaccination
606   $aHepatitis B vaccine
606   $aDemyelination$xVaccination
606   $aImmunization$xComplications
606   $aVaccination$xComplications
608   $aElectronic books.
615  0$aHepatitis B$xVaccination.
615  0$aHepatitis B vaccine.
615  0$aDemyelination$xVaccination.
615  0$aImmunization$xComplications.
615  0$aVaccination$xComplications.
676   $a614.593
701   $aStratton$b Kathleen R$0857330
701   $aAlmario$b Donna A$01043988
701   $aMcCormick$b Marie C$01034673
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456012803321
996   $aImmunization safety review$92469310
997   $aUNINA